Barclays PLC Pulmonx Corp Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Pulmonx Corp stock. As of the latest transaction made, Barclays PLC holds 94,109 shares of LUNG stock, worth $578,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,109

Previous 94,109 -0.0%

Holding current value

$578,770

Previous $780,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$5.59 - $8.58 $9,385 - $14,405	1,679 Added 1.82%	94,109 $780,000
Q2 2024 Aug 14, 2024	SELL	$5.77 - $9.82 $117,581 - $200,111	-20,378 Reduced 18.06%	92,430 $586,000
Q1 2024 May 15, 2024	SELL	$8.71 - $14.65 $213,525 - $359,144	-24,515 Reduced 17.85%	112,808 $1.05 Million
Q4 2023 Feb 15, 2024	BUY	$7.89 - $13.14 $350,197 - $583,218	44,385 Added 47.76%	137,323 $1.75 Million
Q3 2023 Nov 07, 2023	BUY	$9.88 - $14.0 $523,649 - $742,014	53,001 Added 132.71%	92,938 $960,000
Q2 2023 Aug 03, 2023	BUY	$10.78 - $13.65 $242,970 - $307,657	22,539 Added 129.55%	39,937 $524,000
Q1 2023 May 04, 2023	BUY	$7.49 - $12.54 $60,773 - $101,749	8,114 Added 87.4%	17,398 $194,000
Q4 2022 Feb 13, 2023	BUY	$4.92 - $17.35 $38,051 - $134,184	7,734 Added 498.97%	9,284 $79,000
Q3 2022 Nov 03, 2022	SELL	$15.35 - $23.99 $15,518 - $24,253	-1,011 Reduced 39.48%	1,550 $26,000
Q2 2022 Aug 12, 2022	SELL	$14.0 - $27.95 $52,752 - $105,315	-3,768 Reduced 59.54%	2,561 $37,000
Q1 2022 May 16, 2022	BUY	$21.13 - $35.65 $133,731 - $225,628	6,329 New	6,329 $157,000

Others Institutions Holding LUNG

# of Institutions

124

Shares Held

31M

Call Options Held

300

Put Options Held

204K

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $229M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account